Skin Cancer | Tumor

CURE’s skin cancer page is an extensive resource of cancer information featuring the latest skin cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on skin cancer.

Dick Vitale Receives Jimmy V Award, Cancer Survivor Will Use Golf Scholarship to Study Medicine and More

July 22nd 2022

From Dick Vitale receiving the Jimmy V Award at the 2022 ESPYs to a former triathlon champion opening up about his cancer experience, here’s what’s happening in the cancer space this week.

Educated Patient® Skin Cancer Summit Treating Skin Cancer Panel: June 18, 2022

July 17th 2022

Watch Dr. Jedd D. Wolchok, Lorenzo Cohen, Dr. Anna C. Pavlick and Julie Bain answer questions about treating skin cancer, during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Demystifying Clinical Trials Presentation: June 18, 2022

July 16th 2022

Watch Dr. Anna C. Pavlick, from Weill Cornell Medicine, discuss clinical trials during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Integrative Care Presentation: June 18, 2022

July 15th 2022

Watch Lorenzo G. Cohen, from The University of Texas MD Anderson Cancer Center, discuss integrative care during the CURE Educated Patient Skin Cancer Summit.

Amazon and Fred Hutch Partner to Investigate Safety, Efficacy of Cancer Vaccine

July 14th 2022

Amazon and Fred Hutchinson Cancer Center recently launched an early-phase clinical trial to assess the safety and efficacy of a cancer vaccine in the treatment of patients with late-stage skin cancer or hormone receptor-positive, HER2-negative breast cancer.

Educated Patient® Skin Cancer Summit Basics of Immunotherapy Presentation: June 18, 2022

July 14th 2022

Watch Dr. Jedd D. Wolchok, from Memorial Sloan Kettering Cancer Center, discuss immunotherapy, during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Multidisciplinary Approach Panel: June 18, 2022

July 13th 2022

Watch Dr. Sherrif Ibrahim, Dr. Erica B. Friedman and Dr. Nicholas Sanfilippo answer questions about the multidisciplinary approach to care during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Radiation Presentation: June 18, 2022

July 12th 2022

Watch Dr. Nicholas Sanfilippo, from Weill Cornell Medicine, discuss radiation therapy options during the CURE Educated Patient Skin Cancer Summit.

In Recent Decades, Immunotherapy Extended Advanced Melanoma Survival from Months to Years

July 11th 2022

Thanks to the FDA approval of immunotherapy agents, the average survival for patients for stage 4 melanoma has drastically increased over the past 20 years, an expert explained.

Educated Patient® Skin Cancer Summit Surgery Presentation: June 18, 2022

July 11th 2022

Watch Dr. Erica B. Friedman, from NYU Grossman School of Medicine, discuss surgery, during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Topical Treatments Presentation: June 18, 2022

July 10th 2022

Watch Dr. Sherrif Ibrahim, from the University of Rochester Medical Center, discuss topical treatments during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit The Basics Panel: June 18, 2022

July 9th 2022

Watch Dr. Barbara Ma, Dr. Evan Lipson, Dr. Sunandana Chandra and Samantha Guild answer questions on the basics of skin cancer and melanoma during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Melanoma Presentation: June 18, 2022

July 8th 2022

Watch Dr. Sunandan Chandra, from Northwestern University Feinberg School of Medicine, discuss the basics of melanoma, during the CURE Educated Patient Skin Cancer Summit.

Dealing With People’s Reactions to Cancer: From Empathy to Sympathy

July 7th 2022

I prefer when people respond with empathy when they hear about my wife’s death from cancer, though I’m often met with sympathy first.

Educated Patient® Skin Cancer Summit Merkel Cell Carcinoma Presentation: June 18, 2022

July 7th 2022

Watch Dr. Evan J. Lipson, from Johns Hopkins Medicine, discuss Merkel cell carcinoma, during the CURE Educated Patient Skin Cancer Summit.

Educated Patient® Skin Cancer Summit Basal Cell Carcinoma/Squamous Cell Carcinoma Presentation: June 18, 2022

July 6th 2022

Watch Dr. Barbara Ma, from Weill Cornell Medicine, discuss the basics of basal and squamous cell carcinomas during the CURE Educated Patient Skin Cancer Summit.

Keytruda Demonstrates Significant Improvement for Some Patients with Melanoma

June 9th 2022

Keytruda, an immunotherapy agent, demonstrated significant improvement in both distant metastasis-free survival and recurrence-free survival compared to placebo.

Trial Will Investigate Drug Duo in Solid Cancers With MAPK Pathway Aberrations

May 25th 2022

Patients can still talk to their clinicians about enrolling in a sub-study of the FIRELIGHT-1 trial, analyzing tovorafenib plus pimasertib in progressive or refractory solid tumors with MAPK pathway aberrations.

PGA Tour Golfer Justin Thomas Urges People to Check for Melanoma, ‘One Life to Live’ and ‘As the World Turns’ Actress Marnie Schulenburg Dies from Cancer and More

May 20th 2022

From PGA Tour golfer Justin Thomas’ new sun-protection line to soap opera actress Marnie Schulenburg’s breast cancer death and the first child to receive CAR-T cell therapy celebrating 10 years cancer-free, here’s what’s happening in the cancer space this week.

No Matter the Obstacle Thrown in Our Faces, Cancer Advocates Will Always Succeed

May 13th 2022

I like to think that cancer advocates live the motto of the postal service, “Neither snow nor rain nor heat nor gloom of night stays these couriers from their swift completion of their appointed rounds.”

First-in-Human Trial Assessing Novel Drug in Patients With Solid Tumors Launches

May 12th 2022

The primary objective of the early-stage trial is to determine the maximum tolerated dose of the novel drug in a group of patients with recurrent and/or refractory solid tumors.

Skin Cancer Diagnosis, Older Age May Be Associated With Increased Risk for Rare Skin Condition from Immunotherapy Treatment

April 19th 2022

Patients within the study who developed the rare skin condition were more likely to experience better tumor responses than those who did not develop the side effect.

I Have Some Regrets Around How I Handled My Wife’s Cancer

April 17th 2022

Upon reflecting on my late wife's cancer experience, one of my major regrets is not properly saying goodbye.

Opdivo-Yervoy Combo Induces Survival Benefit in Advanced Skin Cancer

April 14th 2022

Compared with Yervoy alone, the use of Yervoy plus Opdivo was associated with a significant survival benefit as a second-line treatment in patients with previously treated advanced melanoma, a type of skin cancer.

Trial of Direct-to-Tumor Skin Cancer Drug Doses First Patient

April 7th 2022

A phase 2 trial will investigate LTX-315 in patients with basal cell carcinoma, the most common form of skin cancer.

Early-Stage Clinical Trial Treats First Patient With Life-Threatening Cancer Metastases With Investigational Drug

March 30th 2022

It is expected that up to 18 patients with leptomeningeal metastases — a serious form of cancer that has spread from its original location to an area surrounding the brain and spinal cord — will receive treatment with the investigational drug.

Cancer Conferences Helped Me Grow as an Advocate

March 25th 2022

At first, I struggled to keep up with the scientific jargon being presented at a cancer conference, but eventually I hit my stride and now I leave these events with a renewed sense of inspiration.

Swapping Surgery for Adjuvant Therapy May Improve Outcomes in Patients With Stage 3 Melanoma

March 23rd 2022

Patients with stage 3 melanoma, a type of skin cancer, that has metastasized to the lymph nodes may benefit from skipping lymph node removal surgery and receiving treatment with adjuvant therapy, although more research is needed in this area.

Opdivo Plus Experimental Drug Combo Fails to Improve Survival, Response Rates in Patients With Advanced Melanoma

March 22nd 2022

The use of bempegaldesleukin and Opdivo failed to meet its goal of significantly improving progression-free survival and responses to treatment, compared with Opdivo alone in patients with previously untreated unresectable or metastatic melanoma, according to data from an initial analysis of the phase 3 PIVOT IO-001 study.

FDA Approves Opdualag, a New Fixed-Dose Combination Treatment, For Certain Patients With Skin Cancer

March 19th 2022

The FDA’s decision to greenlight Opdualag is based on data that showed that the combination more than doubled survival without disease progression when compared with Opdivo in patients with previously untreated metastatic or unresectable melanoma, a type of skin cancer.

NEXT PAGE
PREVIOUS PAGE